Studies on specific genes in the brain induced by DOPA and their function.

多巴诱导的大脑特定基因及其功能的研究。

基本信息

  • 批准号:
    14570599
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2004
  • 项目状态:
    已结题

项目摘要

To clarify the molecular events in the brain of parkinsonian who treated with levodopa of anti-parkinsonian drugs, we investigated the genes in the nigrostriatal pathway of parkinsonian model animals specifically induced by levodopa treatment, and also analyzed their function, as follows :1.Screening of expressed genes in the brain of parkinsonian models after levodopa treatmentWe screened the specific genes which expressed in the striatum of hemi-parkinsonian model rats after levodopa treatment by using differential display method. A proapoptotic gene, p53-activated gene 608(PAG608) was identified as a DOPA-induced gene in parkinsonian brain.2.Role of PAG608 in oxidative stress-induced apoptosis in dopaminergic neuronal cellsIn the catecholaminergic cells, inhibition of PAG608 expression by the transfection with antisense PAG608 cDNA blocked 6-hydroxydopamine-or hydrogen peroxide-induced cell death, increases in p53 and Bax expression, reduction of mitochondrial membrane potential, ac … More tivation of caspase-3 and DNA fragmentation. Although PAG608 is activated by p53, overexpression of PAG608 by the transfection of PAG608 gene inversely increased p53 expression. Furthermore, we clarified that the translocation of PAG608 to the nucleus and nucleolus is necessary for induction of apoptosis.3.Involvement of PAG608 in_dopamine-or methamphetamine-induced neurotoxicityThe inhibition of PAG608 expression by the transfection with antisense PAG608 cDNA also blocked excess dopamine-or methamphetamine-induced dopaminergic cell death and their apoptotic morphological changes.4.Expression of PAG608 in the brain of levodopa-treated parkinsonian model ratsPAG608 constitutively expressed in the pontine nucleus, motor nuclei of trigeminal nerve and facial nerve. In the internal capsule, PAG608 expression was strongly induced in the parkinsonian side of levodopa-treated group.These experimental results suggest that PAG608 is generally involved in the common pathway of dopaminergic neuronal death induced by the treatment of levodopa or methamphetamine and that it is a molecule specifically induced by excess amount of dopamine in the basal ganglia of parkinsonian models. Less
为了阐明抗帕金森病药物左旋多巴治疗后脑内的分子事件,我们对左旋多巴治疗特异性诱导的帕金森病模型动物黑质纹状体通路中的基因进行了研究,并对其功能进行了分析,如下:1.左旋多巴治疗后帕金森病模型脑内表达基因的筛选我们筛选了表达的特异基因。 采用差异显示法观察左旋多巴治疗后的半侧帕金森病模型大鼠纹状体。帕金森病脑中发现促凋亡基因p53激活基因608(PAG608)是多巴诱导的基因。2.PAG608在氧化应激诱导的多巴胺能神经元细胞凋亡中的作用在儿茶酚胺能细胞中,转染反义PAG608 cDNA抑制PAG608的表达 阻断 6-羟基多巴胺或过氧化氢诱导的细胞死亡,增加 p53 和 Bax 表达,降低线粒体膜电位,激活 caspase-3 和 DNA 片段化。尽管PAG608被p53激活,但是通过转染PAG608基因而过度表达PAG608反而增加了p53的表达。此外,我们还阐明PAG608易位到细胞核和核仁对于诱导细胞凋亡是必要的。3.PAG608参与多巴胺或甲基苯丙胺诱导的神经毒性转染反义PAG608 cDNA抑制PAG608表达也阻断了过量的多巴胺或甲基苯丙胺诱导的神经毒性。 甲基苯丙胺诱导的多巴胺能细胞死亡及其凋亡形态学变化。4.左旋多巴帕金森病模型大鼠脑内PAG608的表达PAG608在脑桥核、三叉神经运动核和面神经中组成型表达。在内囊中,左旋多巴治疗组的帕金森病一侧强烈诱导PAG608表达。这些实验结果表明,PAG608普遍参与了左旋多巴或甲基苯丙胺治疗诱导的多巴胺能神经元死亡的共同途径,并且它是在基底节中特异性诱导过量多巴胺的分子。 帕金森模型。较少的

项目成果

期刊论文数量(116)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tanaka, K., et al.: "Molecular basis of anti-apoptotic effects of immunophilin ligands on hydrogen peroxide-induced apoptosis in human glioma cells."Neurochem.Res.. (In press). (2004)
Tanaka, K. 等人:“亲免素配体对过氧化氢诱导的人神经胶质瘤细胞凋亡的抗凋亡作用的分子基础。”Neurochem.Res..(正在出版)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Asanuma, M., et al.: "Methamphetamine-induced neurotoxicity in mouse brain is attenuated by ketoprofen, a non-steroidal anti-inflammatory drug."Neurosci.Lett.. 352・1. 13-16 (2003)
Asanuma, M., et al.:“酮洛芬(一种非甾体类抗炎药)可以减轻甲基苯丙胺诱导的小鼠脑神经毒性。”Neurosci.Lett. 352・1 (2003)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ogawa, N, Tanaka, K.: "Immunosuppressant Analogs in Neuroprotection (ed. : Borlongan, C. V., Isacson, O. and Sanberg, P. R.)"Humana Press, Totowa. 378 (2002)
小川,N,田中,K.:“神经保护中的免疫抑制剂类似物(编辑:Borlongan,C.V.,Isacson,O. 和 Sanberg,P.R.)”Humana Press,Totowa。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Pramipexole has ameliorating effects on levodopa-induced abnormal dopamine turnover in parkinsonian striatum and quenching effects on dopanilne-semiquinone generated in vitro.
普拉克索对左旋多巴诱导的帕金森纹状体多巴胺转换异常具有改善作用,并对体外产生的多巴尼半醌具有猝灭作用。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Asanuma;M.;et al.
  • 通讯作者:
    et al.
Parkin attenuates manganese-induced dopaminergic cell death
  • DOI:
    10.1111/j.1471-4159.2004.02445.x
  • 发表时间:
    2004-06-01
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
    Higashi, Y;Asanuma, M;Ogawa, N
  • 通讯作者:
    Ogawa, N
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OGAWA Norio其他文献

OGAWA Norio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OGAWA Norio', 18)}}的其他基金

Molecular function of metallothionein-III in parkinsonism with drug treatment
金属硫蛋白-III在帕金森病药物治疗中的分子功能
  • 批准号:
    11670629
  • 财政年份:
    1999
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanim of cytotoxicity induced by dopamine and 6-hydroxydopamine
多巴胺和6-羟基多巴胺诱导细胞毒性的分子机制
  • 批准号:
    08670708
  • 财政年份:
    1996
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular pathophysiology of dopamine receptors in dyskinesia
运动障碍多巴胺受体的分子病理生理学
  • 批准号:
    04670489
  • 财政年份:
    1992
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Biochemical and pharmacolotical pathogenesis of dyskinesia in the IDPN-treated rat model
IDPN 治疗的大鼠模型运动障碍的生化和药理学发病机制
  • 批准号:
    01570449
  • 财政年份:
    1989
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Interactions between Classical Neurotransmitter Systems and Neuropeptide Systems in Experimental Animal Model of Parkinsonism
帕金森病实验动物模型中经典神经递质系统与神经肽系统的相互作用
  • 批准号:
    61570387
  • 财政年份:
    1986
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Elucidation of the pathogenesis of levodopa-induced dyskinesia that contributes to the development of new therapies targeting the serotonergic system
阐明左旋多巴引起的运动障碍的发病机制,有助于开发针对血清素能系统的新疗法
  • 批准号:
    23K14786
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Brain magnetic stimulation to reduce levodopa-induced dyskinesias in Parkinson's disease
脑磁刺激可减少帕金森病中左旋多巴引起的运动障碍
  • 批准号:
    488794
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Operating Grants
The impact of levodopa-induced dyskinesia on the physical and social participation of patients with advanced Parkinson's disease and their spousal caregiver: a digital phenotyping study.
左旋多巴引起的运动障碍对晚期帕金森病患者及其配偶照顾者的身体和社会参与的影响:一项数字表型研究。
  • 批准号:
    477646
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Operating Grants
The impact of levodopa-induced dyskinesia on the physical and social participation of patients with advanced Parkinson's disease and their spousal caregiver: a digital phenotyping study.
左旋多巴引起的运动障碍对晚期帕金森病患者及其配偶照顾者的身体和社会参与的影响:一项数字表型研究。
  • 批准号:
    472325
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Operating Grants
Mechanisms and effects of pallidal deep brain stimulation on levodopa resistant motor signs in Parkinson's disease
苍白球深部脑刺激对帕金森病左旋多巴抵抗运动体征的机制和影响
  • 批准号:
    10282963
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
Mechanisms and effects of pallidal deep brain stimulation on levodopa resistant motor signs in Parkinson's disease
苍白球深部脑刺激对帕金森病左旋多巴抵抗运动体征的机制和影响
  • 批准号:
    10703246
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
Mechanisms and effects of pallidal deep brain stimulation on levodopa resistant motor signs in Parkinson's disease
苍白球深部脑刺激对帕金森病左旋多巴抵抗运动体征的机制和影响
  • 批准号:
    10489834
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
Association entre la dose de levodopa-carbidopa, le déficit en vitamine B6 et la polyneuropathie dans les syndromes parkinsoniens
左旋多巴-卡比多巴剂量、维生素 B6 缺乏与帕金森综合症多发性神经病的关系
  • 批准号:
    466925
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Studentship Programs
Pathophysiology and treatment for levodopa-induced dyskinesia in a rat model of Parkinson's disease
帕金森病大鼠模型中左旋多巴引起的运动障碍的病理生理学和治疗
  • 批准号:
    20K16570
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Glial-mediated abnormal neuroplasticity in levodopa-induced dyskinesia
左旋多巴引起的运动障碍中胶质细胞介导的异常神经可塑性
  • 批准号:
    20K07865
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了